-
-
-
-
-
-
-
Arno Therapeutics Reports First Quarter 2016 Financial and Business Update
-
-
-
-
-
-
-
Arno Therapeutics Data Demonstrate AR-12 as Novel Antifungal Drug Against Common Finger and Toenail Fungus, Onychomycosis
-
-
-
-
-
-
-
Arno Therapeutics Data Demonstrates Novel Antimicrobial Activity of AR-12, Identified it as Lead Compound of New Class of Drugs
-
-
-
-
-
-
-
Arno Therapeutics Reports Second Quarter 2015 Financial Results and Business Update
-
-
-
-
-
-
-
Arno Therapeutics Reports First Quarter 2015 Financial and Business Update
-
-
-
-
-
-
-
Arno Therapeutics Receives European Orphan Drug Designation for AR-12 to Treat Two Infectious Diseases
-
-
-
-
-
-
-
Arno Therapeutics Reports Third Quarter 2014 Financial and Business Update
-
1,200,695 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

